Alnylam Pharma(CH:DUL)
CHF 138.580.00 (0.00%)
CH:DUL
Alnylam Pharma earnings date
CHF 138.58
At close:0.00 (0.00%)
Alnylam Pharma (DUL) Earnings Dates, Call Summary & Reports
0 Followers
Earnings Data
- Estimated Report Date
- Feb 18, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- 1.42
- Last Year’s EPS
- 0.68
TBA (Not Confirmed)
Same Quarter Last Year
Alnylam Pharma (CH:DUL) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
CH:DUL Q3 2026 Earnings Report
CH:DUL Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
CH:DUL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 1.42- | 0.68 | ― | ― | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.3712.98 | 1.52 | 754.35% (+11.46) | |||
| Jul 30, 2026 | 2026 (Q2) | 1.351.00 | -0.42 | 337.25% (+1.42) | |||
| Apr 30, 2026 | 2026 (Q1) | 0.721.25 | -0.36 | 443.18% (+1.61) | |||
| Feb 12, 2026 | 2025 (Q4) | 0.950.68 | -0.54 | 226.15% (+1.21) | |||
| Oct 30, 2025 | 2025 (Q3) | 0.461.52 | -0.72 | 311.49% (+2.24) | |||
| Jul 31, 2025 | 2025 (Q2) | -0.45-0.42 | -0.11 | -292.31% (-0.31) | |||
| May 01, 2025 | 2025 (Q1) | -0.73-0.36 | -0.43 | 15.38% (+0.07) | |||
| Feb 13, 2025 | 2024 (Q4) | -0.49-0.54 | -0.91 | 40.91% (+0.37) | |||
| Oct 31, 2024 | 2024 (Q3) | -0.76-0.72 | 0.95 | -175.65% (-1.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
CH:DUL Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2026 | CHF190.53 | CHF138.58 | -27.27% |
| Jul 30, 2026 | CHF183.73 | CHF166.56 | -9.35% |
| Apr 30, 2026 | CHF228.98 | CHF228.98 | +0.00% |
| Feb 12, 2026 | CHF228.98 | CHF228.98 | +0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Alnylam Pharma (CH:DUL) report earnings?
Alnylam Pharma (CH:DUL) is estimated to report earnings on Feb 18, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is CH:DUL EPS forecast?
CH:DUL EPS forecast for the fiscal quarter 2026 (Q4) is 1.42.

